Hearing Loss and Brain Health Study
NCT: NCT07288463 · NOT_YET_RECRUITING
Brief Summary
Hearing loss is a prevalent and modifiable risk factor for cognitive decline and dementia in older adults, yet access to hearing care remains limited. Over-the-counter (OTC) hearing aids represent a promising and scalable strategy to expand access, particularly for individuals at elevated risk for dementia who may benefit most from earlier intervention. This pilot study aims to evaluate the feasibility and acceptability of OTC hearing aid use among older adults. Participants aged ≥50 years will undergo standardized hearing screening to identify bilateral, mild-to-moderate hearing loss. Eligible participants will be randomized to one of two sequences: (1) immediate intervention: 3-mo using OTC hearing aids or (2) waitlist control: 3-mo without devices followed by OTC hearing aid use after 3 months. Feasibility outcomes include study enrollment and retention, protocol adherence, and average daily device use determined by data-logging. Acceptability outcomes will be assessed using the International Outcome Inventory for Hearing Aids (IOI-HA), device satisfaction ratings, and participant intention to continue hearing-aid use. Hearing outcomes include validated questionnaires on hearing and listening efforts. Findings will inform the design of larger trials aimed at improving access to hearing care and promoting cognitive health.
Frequently Asked Questions
What is Hearing Loss and Brain Health Study?
Hearing Loss and Brain Health Study is a clinical trial registered under NCT07288463. Current status: NOT_YET_RECRUITING.
What is the status of NCT07288463?
The current status of NCT07288463 (Hearing Loss and Brain Health Study) is: NOT_YET_RECRUITING.
When did Hearing Loss and Brain Health Study start?
Hearing Loss and Brain Health Study started on 2027-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.